AREC - DPW ANVS and CFMS among pre market gainers

Socket Mobile SCKT +79% on Q2 earningsAlzamend Neuro ALZN +62% after data showing safety of Alzheimer’s therapy in mouse studyVeoneer VNE +55% on earningsAcorda Therapeutics ACOR+49% on INBRIJA distribution and supply dealNRx Pharmaceuticals (NRXP) +52%.Medigus (MDGS) +19% Polyrizon’s innovative proprietary technology found effective against coronavirus in a pre-clinical studyXenetic Biosciences (XBIO) +17%.Snap  (SNAP) +17% on Q2 earningsCyclerion Therapeutics (CYCN) +17%.Universe Pharmaceuticals (UPC) +13%.NeuroMetrix (NURO) +11%.Abeona Therapeutics ABEO +8% activates second site in EB-101 late-stage connective tissue disorder studyAult Global Holdings  (DPW) +9%.Annovis Bio (ANVS) +7%.Conformis (CFMS) +7%.Skechers U.S.A SKX +7% on Q2 earningsVinco Ventures (BBIG) +6%.American Resources Corporation (AREC) +6%.Aerpio Pharmaceuticals (ARPO) +6%.IMV (IMV) +4%.

For further details see:

DPW, ANVS and CFMS among pre market gainers